α1-Acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties

Schmid, 1977, The carbohydrate units of human plasma α1-acid glycoprotein, Biochim. Biophys. Acta, 492, 291, 10.1016/0005-2795(77)90080-0 Yoshima, 1981, Comparative study of the carbohydrate moieties of rat and human plasma α1-acid glycoproteins, J. Biol. Chem., 256, 8476, 10.1016/S0021-9258(19)68868-X Fournier, 2000, α1-Acid glycoprotein, Biochim. Biophys. Acta, 1482, 157, 10.1016/S0167-4838(00)00153-9 Mackiewicz, 1987, Microheterogeneity forms of α1-acid glycoprotein as indicators of rheumatoid arthritis activity, Clin. Chim. Acta, 163, 185, 10.1016/0009-8981(87)90021-0 Turner, 1992, N-glycosylation of serum proteins in disease and its investigation using lectins, Clin. Chim. Acta, 208, 149, 10.1016/0009-8981(92)90073-Y de Graaf, 1993, Inflammation-induced expression of sialyl LewisX-containing glycan structures on α1-acid glycoprotein (orosomucoid) in human sera, J. Exp. Med., 177, 657, 10.1084/jem.177.3.657 van Dijk, 1994, Changes in glycosylation of acute-phase proteins in health and disease: occurrence, regulation and function, Glycol. Dis., 1, 5, 10.1007/BF00917463 van Dijk, 1995, α1-Acid glycoprotein (orosomucoid): pathophysiological changes in glycosylation in relation to its function, Glycoconjugate J., 12, 227, 10.1007/BF00731324 Mackiewicz, 1987, Monokines regulate glycosylation of acute-phase proteins, J. Exp. Med., 166, 253, 10.1084/jem.166.1.253 Mackiewicz, 1989, Interferon β2/B-cell stimulating factor 2/interleukin 6 affects glycosylation of acute phase proteins in human hepatoma cell lines, Scand. J. Immunol., 29, 265, 10.1111/j.1365-3083.1989.tb01124.x van Dijk, 1991, Inflammation-induced changes in expression and glycosylation of genetic variants of α1-acid glycoprotein Studies with human sera primary cultures of human hepatocytes and transgenic mice, Biochem. J., 276, 343, 10.1042/bj2760343 Pous, 1992, Recombinant human interleukin 1β and tumor necrosis factor affect glycosylation of serum α1-acid glycoprotein in rats, Inflammation, 16, 197, 10.1007/BF00918809 Mackiewicz, 1993, Leukemia inhibitory factor, interferon-γ and dexamethasone regulate N-glycosylation of α1-protease inhibitor in human hepatoma cells, Eur. J. Cell Biol., 60, 331 Azuma, 2000, Alteration of sugar chains on α1-acid glycoprotein secreted following cytokine stimulation of HuH-7 cells in vitro, Clin Chim. Acta, 294, 93, 10.1016/S0009-8981(99)00248-X Kremer, 1988, Drug binding to human α1-acid glycoprotein in health and disease, Pharmacol. Rev., 40, 1 Israili, 2001, Human α1-glycoprotein and its interactions with drugs, Drug Metab. Rev., 33, 161, 10.1081/DMR-100104402 Logdberg, 2000, Immunocalins: a lipocalin subfamily that modulates immune and inflammatory responses, Biochim. Biophys. Acta, 1482, 284, 10.1016/S0167-4838(00)00164-3 Chiu, 1977, Interactions of α1-acid glycoprotein with the immune system. I. Purification and effects upon lymphocyte responsiveness, Immunology, 32, 997 Wu, 1999, Signal pathway of mitogen-induced Ca2+-activated K+ currents in young and aged T-cell clones of C57BL/6 mice, Cell Signal, 11, 391, 10.1016/S0898-6568(99)00011-X Cheresh, 1984, Interaction of an acute phase reactant, α1-acid glycoprotein (orosomucoid), with the lymphoid cell surface: a model for non-specific immune suppression, Immunology, 51, 541 Blackwell, 1982, Glucocorticoids induce the formation and release of anti-inflammatory and anti-phospholipase proteins into the peritoneal cavity of the rat, Br. J. Pharmacol., 76, 185, 10.1111/j.1476-5381.1982.tb09205.x Lee, 1979, Adsorbed glycoproteins in platelet adhesion onto polymer surfaces: significance of terminal galactose units, Trans. Am. Soc. Artif. Intern. Organs, 25, 124, 10.1097/00002480-197902500-00025 Elg, 1997, α1-Acid glycoprotein is an immunosuppressive factor found in ascites from ovaria carcinoma, Cancer, 80, 1448, 10.1002/(SICI)1097-0142(19971015)80:8<1448::AID-CNCR12>3.0.CO;2-5 Bennett, 1980, Immunosuppression by human plasma α1-acid glycoprotein: importance of the carbohydrate moiety, Proc. Natl. Acad. Sci. U.S.A., 77, 6109, 10.1073/pnas.77.10.6109 Pos, 1990, Con A-nonreactive human α1-acid glycoprotein (AGP) is more effective in modulation of lymphocyte proliferation than Con A-reactive AGP serum variants, Inflammation, 14, 133, 10.1007/BF00917452 Singh, 1986, Lymphocyte stimulation in vitro by orosomucoid glycoprotein, Immunol. Lett., 14, 9, 10.1016/0165-2478(86)90013-1 Shiian, 1994, Conjugates and carbohydrate chains of α1-acid glycoprotein with polyacrylamide maintain the immunomodulating activity of native glycoprotein, Bioorg. Khim., 20, 994 Tamura, 1981, Isolation and characterization of an immunosuppressive acidic protein from acidic fluids of cancer patients, Cancer Res., 41, 3244 Samak, 1982, Immunosuppressive effect of acute-phase reactant proteins in vitro and its relevance to cancer, Cancer Immunol. Immunother., 13, 38, 10.1007/BF00200198 Watanabe, 1986, Purification and characterization of mouse α1-acid glycoprotein and its possible role in the antitumor activity of some lichen polysaccharides, Chem. Pharm. Bull. (Tokyo), 34, 2532, 10.1248/cpb.34.2532 Thomas, 1989, The expression of α1-acid glycoprotein mRNA during rat development. High levels of expression in the decidua, J. Biol. Chem., 264, 5784, 10.1016/S0021-9258(18)83618-3 Thomas, 1993, Distribution of α2-macroglobulin and α1-acid glycoprotein mRNA shows regional specialization in rat decidua, Placenta, 14, 417, 10.1016/S0143-4004(05)80462-X Costello, 1984, Inhibition of neutrophil activation by α1-acid glycoprotein, Clin. Exp. Immunol., 55, 465 Lainé, 1990, Modulation of human polymorphonuclear neutrophil functions by α1-acid glycoprotein, Inflammation, 14, 1, 10.1007/BF00914025 Dirienzo, 1987, α1-Acid glycoprotein (α1-AGP) on the membrane of human lymphocytes: possible involvement in cellular activation, Immunol. Lett., 15, 167, 10.1016/0165-2478(87)90049-6 Vasson, 1994, Effects of α1-acid glycoprotein on human polymorphonuclear neutrophils: influence of glycan microheterogeneity, Clin. Chim. Acta, 224, 65, 10.1016/0009-8981(94)90121-X Heyworth, 1986, Further evidence for the involvement of a phosphoprotein in the respiratory burst oxidase of human neutrophils, Biochem. J., 239, 723, 10.1042/bj2390723 Snyder, 1976, Inhibition of platelet aggregation by α1-acid glycoprotein, Arch. Intern. Med., 136, 778, 10.1001/archinte.136.7.778 Costello, 1979, Inhibition of platelet aggregation by native and desialised α1-acid glycoprotein, Nature, 281, 677, 10.1038/281677a0 Andersen, 1980, Thrombin-, epinephrine- and collagen-induced platelet aggregation inhibited by α1-acid glycoprotein, Scand. J. Haematol., 24, 365, 10.1111/j.1600-0609.1980.tb02751.x Andersen, 1979, The antiheparin effect of α1-acid glycoprotein probably due to steric hindrance of the heparin-thrombin interaction, Thromb. Res., 15, 857, 10.1016/0049-3848(79)90194-4 Franzblau, 1976, The interaction of collagen with α1-acid glycoprotein, Biochim. Biophys. Acta, 427, 302, 10.1016/0005-2795(76)90306-8 Valles, 1993, Downregulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins, J. Clin. Invest., 92, 1357, 10.1172/JCI116709 Gahmberg, 1978, Leukocyte surface origin of human α1-acid glycoprotein (orosomucoid), J. Exp. Med., 148, 507, 10.1084/jem.148.2.507 Boncela, 2001, Acute phase protein α1-acid glycoprotein interacts with plasminogen activator inhibitor type 1 and stabilizes its inhibitory activity, J. Biol. Chem., 276, 35305, 10.1074/jbc.M104028200 Bories, 1987, Human α1-acid glycoprotein-exposed macrophages release interleukin 1 inhibitory activity, Biochem. Biophys. Res. Commun., 147, 710, 10.1016/0006-291X(87)90988-0 Bories, 1990, Prevalence of tri- and tetraantennary glycans of human α1-acid glycoprotein in release of macrophage inhibitor of interleukin-1 activity, Inflammation, 14, 315, 10.1007/BF00915815 Tilg, 1993, Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1β synthesis by human peripheral blood mononuclear cells, J. Exp. Med., 178, 1629, 10.1084/jem.178.5.1629 Nakamura, 1993, α1-Acid glycoprotein expression in human leukocytes: possible correlation between α1-acid glycoprotein and inflammatory cytokines in rheumatoid arthritis, Inflammation, 17, 33, 10.1007/BF00916390 Boutten, 1992, α1-Acid glycoprotein potentiates lipopolysaccharide-induced secretion of interleukin-1β interleukin-6 and tumor necrosis factor-α by human monocytes and alveolar and peritoneal macrophages, Eur. J. Immunol., 22, 2687, 10.1002/eji.1830221032 Su, 1996, Effects of α1-acid glycoprotein on tissue factor expression and tumor necrosis factor secretion in human monocytes, Immunopharmacology, 34, 139, 10.1016/0162-3109(96)00137-3 Soell, 1995, Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD14 antigen, and mannan binding protein inhibits TNF-α release, J. Immunol., 154, 851, 10.4049/jimmunol.154.2.851 Su, 1999, α1-Acid glycoprotein-induced tumor necrosis factor-α secretion of human monocytes is enhanced by serum binding proteins and depends on protein tyrosine kinase activation, Immunopharmacology, 41, 21, 10.1016/S0162-3109(98)00048-4 Davis, 1997, Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5, J. Exp. Med., 186, 1793, 10.1084/jem.186.10.1793 Atemezem, 2001, Human α1-acid glycoprotein binds to CCR5 expressed on the plasma membrane of human primary macrophages, Biochem. J., 356, 121, 10.1042/0264-6021:3560121 Scuderi, 1989, Alpha-globulins suppress human leukocyte tumor necrosis factor secretion, Eur. J. Immunol., 19, 939, 10.1002/eji.1830190523 Maeda, 1980, The growth-stimulating effect of α1-acid glycoprotein in cells in culture, Proc. Soc. Exp. Biol. Med., 163, 223, 10.3181/00379727-163-40751 Liu, 1988, In vitro nerve-growth-promoting activity of human plasma α1-acid glycoprotein, J. Neurosci. Res., 20, 64, 10.1002/jnr.490200110 Libert, 1994, Protection by α1-acid glycoprotein against tumor necrosis factor-induced lethality, J. Exp. Med., 180, 1571, 10.1084/jem.180.4.1571 Muchitsch, 1998, Effects of α1-acid glycoprotein in different rodent models of shock, Fundam. Clin. Pharmacol., 12, 173, 10.1111/j.1472-8206.1998.tb00938.x Rothe, 1994, Phenotypic analysis of TNFRI-deficient mice and characterization of TNFRI-deficient fibroblasts in vitro, Circ. Shock, 44, 51 Marino, 1997, Characterization of tumor necrosis factor-deficient mice, Proc. Natl. Acad. Sci. U.S.A., 94, 8093, 10.1073/pnas.94.15.8093 Friedman, 1983, Control of malaria virulence by α1-acid glycoprotein (orosomucoid), an acute-phase (inflammatory) reactant, Proc. Natl. Acad. Sci. U.S.A., 80, 5421, 10.1073/pnas.80.17.5421 Maeda, 1980, Facilitating effects of α1 acid glycoprotein on the passage of erythrocytes through the membrane-filter, Life Sci., 27, 157, 10.1016/0024-3205(80)90458-0 Athamna, 1996, Adherence of Mycoplasma pneumoniae to human alveolar macrophages, FEMS Immunol. Med. Microbiol., 15, 135, 10.1111/j.1574-695X.1996.tb00064.x Hochepied, 2000, Involvement of the acute phase protein α1-acid glycoprotein in nonspecific resistance to a lethal gram-negative infection, J. Biol. Chem., 275, 14903, 10.1074/jbc.275.20.14903 Muchitsch, 1996, In vivo effect of α1-acid glycoprotein on experimentally enhanced capillary permeability in guinea-pig skin, Arch. Int. Pharmacodyn Ther., 331, 313 Sörensson, 2000, Orosomucoid has a cAMP-dependent effect on human endothelial cells and inhibits the action of histamine, Am. J. Physiol. Heart Circ. Physiol., 278, H1725, 10.1152/ajpheart.2000.278.5.H1725 Schnitzer, 1992, Quantitation of specific binding of orosomucoid to cultured microvascular endothelium: role in capillary permeability, Am. J. Physiol., 263, H48 Sörensson, 1999, Human endothelial cells produce orosomucoid, an important component of the capillary barrier, Am. J. Physiol., 276, H530 DeFouw, 1999, Modulation of angiogenic endothelial permselectivity by the cAMP pathway, Microvasc. Res., 57, 19, 10.1006/mvre.1998.9999 van Hinsberg VWM, van Nieuw Amerongen GP, Draijer R. Vascular endothelium. Physiology, pathology and therapeutic opportunities. In: Born GVR, Schwarz, CJ, editors. Regulation of the permeability of human endothelial cell monolayers. Stuttgart: Schattauer, 1997. p. 61–76. Adamson, 1998, Microvascular permeability and number of tight junctions are modulated by cAMP, Am. J. Physiol., 274, H1885 McNamara, 1986, Autacoid binding to serum proteins. Interaction of platelet activating factor (PAF) with human serum α1-acid glycoprotein (AAG), Biochem. Pharmacol., 35, 621, 10.1016/0006-2952(86)90357-6 Libert, 1995, Platelet-activating factor is a mediator in tumor necrosis factor/galactosamine-induced lethality, J. Inflamm., 46, 139 Wielockx, 2001, Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy, Nat. Med., 7, 1202, 10.1038/nm1101-1202 Moore, 1997, α1-Acid (AAG, orosomucoid) glycoprotein: interaction with bacterial lipopolysaccharide and protection from sepsis, Inflammation, 21, 69, 10.1023/A:1027342909423 Van Molle, 1997, α1-Acid glycoprotein and α1-antitrypsin inhibit TNF-induced but not anti-Fas-induced apoptosis of hepatocytes in mice, J. Immunol., 159, 3555, 10.4049/jimmunol.159.7.3555 Van Molle, 1999, Activation of caspases in lethal experimental hepatitis and prevention by acute phase proteins, J. Immunol., 163, 5235, 10.4049/jimmunol.163.10.5235 Libert, 1998, High-level constitutive expression of α1-acid glycoprotein and lack of protection against tumor necrosis factor-induced lethal shock in transgenic mice, Transgenic Res., 7, 429, 10.1023/A:1008810429645 Mackiewicz, 1991, Acute phase mediated change in glycosylation of rat α1-acid glycoprotein in transgenic mice, Glycobiology, 1, 265, 10.1093/glycob/1.3.265 Daemen, 2000, Functional protection by acute phase proteins α1-acid glycoprotein and α1-antitrypsin against ischemia/reperfusion injury by preventing apoptosis and inflammation, Circulation, 102, 1420, 10.1161/01.CIR.102.12.1420 Brinkman-van der Linden, 1998, Inflammation-induced expression of sialyl LewisX is not restricted to α1-acid glycoprotein but also occurs to a lesser extent on α1-antichymotrypsin and haptoglobin, Glycoconjugate J., 15, 177, 10.1023/A:1006972307166 Haraldsson, 1992, Glomerular permselectivity is dependent on adequate serum concentrations of orosomucoid, Kidney Int., 41, 310, 10.1038/ki.1992.43 Johnsson, 1993, Addition of purified orosomucoid preserves the glomerular permeability for albumin in isolated perfused rat kidneys, Acta Physiol. Scand., 147, 1, 10.1111/j.1748-1716.1993.tb09466.x Brinkman-van der Linden, 1996, A missense mutation in the FUT6 gene results in total absence of α3-fucosylation of human α1-acid glycoprotein, J. Biol. Chem., 271, 14492, 10.1074/jbc.271.24.14492 Williams, 1997, α1-Acid glycoprotein reduces local and remote injuries after intestinal ischemia in the rat, Am. J. Physiol., 273, 1031 Simpson, 1993, Neutrophil and nonneutrophil-mediated injury in intestinal ischemia–reperfusion, Ann. Surg., 218, 444, 10.1097/00000658-199310000-00005 Hill, 1992, Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia–reperfusion in the rat, J. Immunol., 149, 1723, 10.4049/jimmunol.149.5.1723 Meri, 1990, Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H, Proc. Natl. Acad. Sci. U.S.A., 87, 3982, 10.1073/pnas.87.10.3982 Staprans, 1977, The effect of α1-acid glycoprotein (orosomucoid) on triglyceride metabolism in the nephrotic syndrome, Biochem. Biophys. Res. Commun., 79, 1272, 10.1016/0006-291X(77)91143-3 Muchitsch, 2000, Effects of α1-acid glycoprotein on acute pancreatitis and acute lung injury in rats, Arzneimittelforschung, 50, 987 Denko, 1984, Anti-inflammatory action of α1-acid-glycoprotein in urate crystal inflammation, Agents Actions, 15, 539, 10.1007/BF01966770 Hochepied, 2002, Overexpression of α1-acid glycoprotein in transgenic mice leads to sensitisation to acute colitis, Gut, 51, 398, 10.1136/gut.51.3.398 Okayasu, 1990, A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice, Gastroenterology, 98, 694, 10.1016/0016-5085(90)90290-H Agneray J. Glycan microheterogeneity forms of α1-acid glycoprotein (AGP): their identification in biological fluids and variations in their relative proportions in disease states. In: Baumann P, Müller WE, Eap CB, Tillement J-P, editors. α1-Acid glycoprotein: genetics, biochemistry, physiological functions and pharmacology. New York: AR Liss, 1989. p. 47–65.